Regulatory, Market Access, & Quality Compliance Services Across Asia-Pacific

We deliver regulatory affairs, market access, quality compliance, clinical development, authorized representative, product safety certification, testing and sourcing solutions. 

Talk to an Expert
Scientists in white lab coats and safety goggles working with electronic circuit boards and taking notes.Enabling Compliance across Asia Pacific

Navigating Regulation, Enabling Innovation Across Asia Pacific

For over two decades, Cisema has helped global companies navigate regulatory complexity and achieve successful market entry in China and across Asia Pacific. Our specialists work as an extension of your team, providing responsive and practical regulatory, quality, and market access expertise that reduces uncertainty and accelerates outcomes.

Whether you need support with product registration, approvals and certifications, clinical development and trials (CRO services), in-country representation, or quality compliance, Cisema delivers the local knowledge and execution capability to help you grow with confidence across China and Asia Pacific.

How We Help Our Clients

Covering the entire product lifecycle, we provide a comprehensive range of services, from one-off project-based deliverables to specialist consulting or ongoing partnership solutions for larger initiatives.

With extensive experience across Asian markets and industries, Cisema helps clients meet regulatory, quality, clinical and access requirements across China and the Asia Pacific region. Our experts guide clients through complex regulatory frameworks, identifying potential challenges and risks, avoiding non-compliance, and improving efficiency to save you time and money.

We support marketing authorization applications, reporting obligations, and post-market requirements, ensuring alignment with local requirements and the expectations of regulatory agencies. Whether providing strategic advice or on-site support, our team helps you develop tailored solutions that navigate regulations to empower your innovations. 

How We Help Our Clients

Explore Our Services 

Regulatory Affairs

We understand the complexities of managing regulatory affairs across China and the wider APAC region, including CMC requirements for biopharma companies.

From strategic planning to engaging with regulatory authorities, our consultants offer full-spectrum support across the regulatory journey. We act as your authorized representative across the region.

Learn more

Development & Strategy Consulting

Cisema experts will guide you at every stage of product development, ensuring compliance, strategic alignment and a successful market entry. We facilitate interactions with regulatory agencies to streamline the approval process.

Learn more

Market Access

We guide you through the Life Sciences reimbursement landscape, ensuring full regulatory compliance while accelerating approvals. Our team crafts strategic pricing plans, conducts budget impact analyses, and supports NRDL (drug reimbursement) negotiations to optimize your success. 

We also assist with exporter regulatory requirements such as certification documentation, custom codes, pre-submission prerequisites and much more.

Learn more

Medtech CRO: China Clinical Trials, Clinical Evaluation & Observational Studies

Cisema experts will guide you at every stage of product development, ensuring compliance, strategic alignment and a successful market entry. We facilitate interactions with regulatory agencies to streamline the approval process.

Learn more

Vigilance & Post-Market Surveillance

Ensuring patient safety and meeting not only Chinese but also global regulatory requirements can be challenging.

With strong regulatory intelligence and deep expertise in local and regional safety standards, we support clients in developing reliable monitoring systems, ensuring continuous compliance, and achieving long-term quality and success throughout the product lifecycle.

Learn more

Quality & Compliance (Control, Assurance, Inspection)

We provide reliable guidance to ensure your products are compliant market-ready. 

By strengthening quality systems and helping you prepare for and navigate regulatory on-site and remote audits, we ensure seamless quality control, assurance, and compliance across the region. 

Learn more

Product Sourcing Agent

We are your trusted sourcing partner in China and across Asia Pacific, connecting you with a vast network of verified, pre-approved suppliers across diverse industries.

Our sourcing experts manage supplier identification, negotiation, and quality control. Your team can focus on core operations while we streamline and optimize your supply chain.

Learn more

Ready to Navigate Complexity & Achieve Success in China and Across Asia Pacific?

Let Cisema help turn your plans into reality.

Talk to an Expert

Who We Help

To provide the best services to our clients, we divide our expertise and innovative solutions across 8 business sectors. Learn more about how we can help you navigate the region's complexity according to your specific needs.

Medical Devices

We help businesses navigate the evolving Medical Device ecosystem with our extensive expertise. From Clinical Trials to Product Registration and Post-Market Surveillance - learn how we can support your success.

Learn more

In-vitro Diagnostics

With typically stricter clinical validation requirements, our team helps to ensure your IVDs pass all the evaluations necessary to enter the markets and remain compliant.

Learn more

Pharmaceuticals

We support the entire product lifecycle, from target identification through implementation, product extension, and redevelopment, by enabling efficient innovation launch, regulatory submission, and commercialization.

Learn more

Biotech

We provide regulatory support for biopharma submissions, covering classification, clinical trial alignment, GMP compliance, import licensing, and engagement with regulatory authorities. Our expertise helps you understand evolving guidelines, traceability requirements, and HGR regulations to accelerate approval and market access.

Learn more

Cosmetics

We support cosmetic and ingredient manufacturers throughout the full product lifecycle, from pre-registration to post-market. Acting as your “responsible person,” our qualified Cosmetics Quality & Safety Managers handle filings, registrations, ingredient code applications, and testing. We ensure quality compliance and assist in preparation for regulator's audits.

Learn more

Health Foods & Supplements

From sound regulatory strategies to preparing registrations and filings to supporting new raw material approvals, we help bring your products to market smoothly. Our team oversees quality compliance, inspection readiness, and testing of supplements, health foods, and raw materials in accredited local labs, ensuring your products meet all regulatory requirements.

Learn more

Quasi-Drugs

We support foreign manufacturers throughout the entire Korean quasi-drug registration process, from initial feasibility assessment and classification through MFDS submission, Korean labeling, import coordination, and ongoing lifecycle compliance.

Learn more

Veterinary Drugs & Pet Food

We support veterinary drug and pet food manufacturers with registration, import licensing, and compliance. As your local representative, we handle regulatory authority interactions, oversee applications for new ingredients, ensure GMP standards, and manage product testing in certified labs, guiding you from market entry to post-launch.

Learn more

Industrial Goods & Consumer Products

We support companies across many industries with regulatory consulting for products such as electronics, machinery, automotive parts, telecom devices and toys. As your local representative, we handle China certifications, manage authority interactions, coordinate testing and inspections, and support documentation, renewals, and ongoing compliance, guiding you from market entry to post-launch.

Learn more

Learn More About Cisema

Regulatory Affairs Consultants, Cisema, are here to help you access China and Hong Kong

Founded over 20 years ago, we’re proud to remain an independent business. Thanks to our personal approach and deep expertise, we’ve helped companies of all sizes, from ambitious startups to industry leaders, to enter and comply with the Chinese and Asia Pacific markets successfully.

Learn More

How We’ve Helped Clients with Our Expert Guidance

Read about how we work with clients to find solutions, bringing together deep industry knowledge with leading talent.

View More
Previous
Previous

Latest Regulatory News

View More

Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

New requirements could affect how injectable devices, including dermal fillers, are supplied in Hong Kong’s private healthcare sector.

September 29, 2026
Hong Kong Requires MDACS Listing for Injectable Dermal Fillers by March 1, 2027

China Enacts First Healthcare Security Law: Impact on Global Medtech

China’s new Healthcare Security Law affects medical device reimbursement, health economic evidence, payment models, and digital traceability from 2027.

September 25, 2026
China Enacts First Healthcare Security Law: Impact on Global Medtech

Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

BPJPH Regulation No. 4 of 2026 introduces pre-shipment halal verification and LPPH reports for imported goods starting September 2026.

September 25, 2026
Indonesia Mandates Pre-Shipment Halal Verification for Imported Products

China Issues New Compliance Guidelines for Online Veterinary Drug Sales

New CVDA guidelines provide detailed guidance for online veterinary drug sellers and platforms, covering licensing, imports, labeling, prescriptions, and traceability.

September 24, 2026
China Issues New Compliance Guidelines for Online Veterinary Drug Sales

NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China’s NMPA has released YY/T 2029–2026, establishing the world's first AI-BCI EEG dataset quality standard for medical devices ahead of its September 2027 enforcement.

September 23, 2026
NMPA Issues World’s First Industry Standard for Medical Devices Using/Adopting BCI Technology

China Establishes Official Testing Methods for Diclofenac Sodium & Urotropine in Cosmetics

China's NMPA has established two supplementary testing methods to detect prohibited substances in cosmetics with high-sensitivity liquid chromatography.

September 18, 2026
China Establishes Official Testing Methods for Diclofenac Sodium & Urotropine in Cosmetics
Previous
Previous

Contact Our Experts & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal